Cannabidiol and Sodium Channel Pharmacology: General Overview, Mechanism, and Clinical Implications
Back to previous page
| Authors: | Ghovanloo, MR; Ruben, PC |
| Year: | 2021 |
| Journal: | Neuroscientist Article Link (DOI) PubMed |
| Title: | Cannabidiol and Sodium Channel Pharmacology: General Overview, Mechanism, and Clinical Implications |
| Abstract: | Voltage-gated sodium (Nav) channels initiate action potentials in excitable tissues. Altering these channels' function can lead to many pathophysiological conditions. Nav channels are composed of several functional and structural domains that could be targeted pharmacologically as potential therapeutic means against various neurological conditions. Mutations in Nav channels have been suggested to underlie various clinical syndromes in different tissues and in association with conditions ranging from epileptic to muscular problems. Treating those mutations that increase the excitability of Nav channels requires inhibitors that could effectively reduce channel firing. The main non-psychotropic constituent of the cannabis plant, cannabidiol (CBD), has recently gained interest as a viable compound to treat some of the conditions that are associated with Nav malfunctions. In this review, we discuss an overview of Nav channels followed by an in-depth description of the interactions of CBD and Nav channels. We conclude with some clinical implications of CBD use against Nav hyperexcitability based on a series of preclinical studies published to date, with a focus on Nav/CBD interactions. |
Departmental members may update their publication list.